In Re: National Prescription Opiate Litigation

Track this case

Case overview

Case Number:

1:17-md-02804

See also:

Court:

Ohio Northern

Nature of Suit:

P.I.: Other

Multi Party Litigation:

Class Action, Multi-district Litigation

Judge:

Dan Aaron Polster (MDL 28

Firms

Companies

Government Agencies

Sectors & Industries:

  1. April 25, 2019

    Opioid MDL Attys' Concealment Merited Sanction: Drug Cos.

    Plaintiffs' attorneys who hid key witness testimony in the multidistrict opioid litigation were properly sanctioned by having that testimony blocked from a bellwether trial, drug companies told an Ohio federal court on Thursday.

  2. April 18, 2019

    Postpone Opioid MDL Trial? Get Real, Judge Says

    An Ohio federal judge on Thursday said that drug companies in the multidistrict opioid litigation are apparently maneuvering to indefinitely delay a bellwether trial and that the idea isn't even worthy of consideration.

  3. April 16, 2019

    Opioid MDL Attys Say Sanction 'Does Not Fit The Crime'

    Plaintiffs attorneys in the multidistrict opioid litigation are contesting a sanction that would block testimony from an influential doctor whose cooperation they failed to disclose, calling it "a punishment that does not fit the crime."

  4. April 10, 2019

    No More Trial Delays In Opioid MDL, Judge Says

    An Ohio federal judge on Wednesday declared that a highly anticipated bellwether trial in the multidistrict opioid litigation won't be postponed again, a move that follows delays and allegations that the drug companies are stalling.

  5. April 08, 2019

    Opioid MDL Attys Sanctioned For Hiding Doctor's Cooperation

    Plaintiffs attorneys in the multidistrict opioid litigation misled drug company defendants about the cooperation of an influential doctor who has long advised drug companies and can no longer use his testimony at a bellwether trial, according to a newly released Ohio federal court ruling.

  6. April 08, 2019

    BakerHostetler Can't Overturn Opioid MDL Disqualification

    BakerHostetler will remain disqualified from representing Endo Pharmaceuticals in two bellwether cases in the multidistrict opioid litigation, an Ohio federal judge ruled Monday, saying the drugmaker waited too long to cry foul.

  7. April 03, 2019

    BakerHostetler Crossed 'Ethical Line' In Opioid MDL: Gov'ts

    BakerHostetler earned its disqualification from key cases in the multidistrict opioid litigation because it crossed an "ethical line" by enlisting an attorney with potential inside information, local governments told an Ohio federal court Wednesday.

  8. April 02, 2019

    Tribes Get Tentative Green Light In Opioid MDL

    The majority of the claims brought by the Blackfeet Tribe and the Muscogee (Creek) Nation in the opioid multidistrict litigation should be allowed to move forward, a federal magistrate judge has said.

  9. April 01, 2019

    Judge Botched BakerHostetler DQ In Opioid MDL, Endo Says

    Endo Pharmaceuticals Inc. is decrying the disqualification of BakerHostetler from bellwether cases in the multidistrict opioid litigation, asserting that an Ohio federal judge "effectively became a witness" against the law firm during disqualification proceedings.

  10. March 20, 2019

    BakerHostetler DQ'd From Opioid MDL Bellwethers

    An Ohio federal judge on Wednesday disqualified BakerHostetler from two bellwether cases in the multidistrict opioid litigation, citing confidential information that a firm partner viewed while working at the U.S. Department of Justice.